Suppr超能文献

制备异贝壳杉烯酮-KLH 缀合物用于 ELISA 系统。

Preparation of isodesmosine-KLH conjugate for ELISA system.

机构信息

Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, Tokyo, Japan.

出版信息

Chirality. 2020 Apr;32(4):431-436. doi: 10.1002/chir.23175. Epub 2020 Feb 6.

Abstract

Chronic obstructive pulmonary disease (COPD) is a degenerative condition with limited diagnostic detection efficiency. Currently with no available cure, COPD is associated with irreversible elastic tissue degradation in lungs, which results in release of unusual amino acids, isodesmosine and desmosine. These biomarkers are potential key elements in enzyme-linked immunosorbent assay (ELISA), an analytical method, which can detect certain compounds including antigens and proteins in easy and affordable manner. In order to target a biomarker with ELISA, it is necessary to prepare its specific antibody, which can be achieved by immunization of host organism with appropriate antigen containing the biomarker. Although preparation of these types of conjugates has been published, desmosine and isodesmosine used by researchers are obtained from natural sources such as animal tissues. Here, we report the first synthetic preparation of isodesmosine and keyhole limpet hemocyanin (KLH) conjugate from commercially available chiral amino acids and carrier protein. Formation of the core pyridinium of isodesmosine was achieved through key reaction-Chichibabin pyridinium synthesis-to deliver a 1,2,3,5-tetrasubstituted pyridinium amino acid selectively. Further modifications involving KLH and maleimide linker provided the target conjugate, which could potentially invoke an immune response to produce anti-isodesmosine antibody for the ELISA system.

摘要

慢性阻塞性肺疾病(COPD)是一种退行性疾病,其诊断检测效率有限。目前尚无治愈方法,COPD 与肺部不可逆的弹性组织降解有关,这会导致不寻常的氨基酸异迪斯莫斯酸和德斯莫斯酸的释放。这些生物标志物是酶联免疫吸附测定(ELISA)的潜在关键要素,ELISA 是一种分析方法,可以以简单且经济的方式检测某些化合物,包括抗原和蛋白质。为了用 ELISA 靶向生物标志物,有必要制备其特异性抗体,这可以通过用含有生物标志物的适当抗原对宿主进行免疫来实现。尽管已经发表了这些类型的缀合物的制备,但研究人员使用的异迪斯莫斯酸和德斯莫斯酸是从动物组织等天然来源获得的。在这里,我们报告了首次从商业可得的手性氨基酸和载体蛋白合成异迪斯莫斯酸和血蓝蛋白(KLH)缀合物。通过关键反应——奇希巴宾吡啶鎓合成,实现了异迪斯莫斯酸核心吡啶鎓的形成,从而选择性地提供了 1,2,3,5-四取代吡啶鎓氨基酸。进一步涉及 KLH 和马来酰亚胺接头的修饰提供了目标缀合物,该缀合物可能会引发免疫反应,从而为 ELISA 系统产生抗异迪斯莫斯酸抗体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验